Bio-Rad Labs Inc. A buy Wells Fargo & Company
Start price
07.08.23
/
50%
€364.80
Target price
07.08.24
€477.33
Performance (%)
-20.83%
End price
08.08.24
€288.80
Summary
This prediction ended on 08.08.24 with a price of €288.80. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.83%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | -1.966% | -1.966% | -17.189% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Wells Fargo & Company from $550.00 to $525.00. They now have an "overweight" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€355.00
16.06.23
16.06.23
€502.10
16.06.24
16.06.24
-25.32%
17.06.24
17.06.24
